Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients | MicrobiomeTrials← Back to trialsNCT03766321
Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients
CompletedNAINTERVENTIONAL
Trial Details
Start: 2020-07-01Est. Completion: 2025-02-01
Enrollment target: 42 participants Locations- Catholic University of Sacred Heart - Fondazione Policlinico "A. Gemelli", Roma, Italy, Italy
- Clinica Neurologica, Ospedale Clinicizzato "SS Annunziata", Chieti, Italy
- Azienda Ospedaliero Universitaria di Modena, Modena, Italy
- UO Neurofisiopatologia, Azienda Ospedaliera dì Perugia, Perugia, Italy
- NEuroMuscular Omnicentre Centre (NeMO), Fondazione Serena Onlus-Fondazione Policlinico A. Gemelli, Roma, Italy
Other microbiome trials you might be interested in
Amyotrophic Lateral Sclerosis
The goal of this clinical trial is to evaluate whether low-dose colchicine can slow disease progression in patients with…
Milan, ItalyEst. completion May 2028
Amyotrophic Lateral Sclerosis
PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evalua…
Phoenix, United StatesEst. completion Oct 15, 2027